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Introduction
Fungal infections or mycoses are the great neglected diseases of medical history.  There are numerous histories of
viral, bacterial and protozoan infections, for all times and all places, but very few studies of those caused by fungi.
Why? It cannot be because of prevalence. Historical sources and contemporary epidemiological investigations show
that fungal infections were and are ubiquitous in human and animal populations. Everyone in Britain and the United
States in the last half a century would have heard of, if not suffered from, athlete’s foot or thrush. In the first half of
the twentieth century, children feared the school nurse finding ringworm on their scalp and having to endure, not only
the pains of X-ray depilation or having their shaven head painted with gentian violet, but also exclusion from school
and the shame of being stigmatised as ‘unclean’.
It seems that medical historians have followed the agenda of the medical profession in showing relatively little
interest in conditions, such as the majority of cases of mycoses, that do not lead to ‘illness’ as such, but cause
inflammation, irritation and discomfort. Medical history remains dominated by studies of diseases that had, or
continue to have, a high profile within medicine, or have attracted government interest and investment because they
cause significant morbidity or mortality. Yet, the majority experience of ill health was, and is, of self-limiting and self-
treated conditions, where sufferers did not, and do not, consult a doctor and become ‘patients’. In their efforts to
recover ‘the patient’s view’, medical historians have ignored the minor illnesses, injuries and infections that were, and
remain, outside of the medical gaze.
But medical historians have also largely ignored the ailments brought on by medical advances, and here too the
history of fungal infections can be instructive. The grand narrative of Western medicine in the twentieth century was
one of ‘progress’, evidenced by greater, scientifically based knowledge of the aetiology and pathology of disease,
more accurate diagnostics, improved management of symptoms and pain, more effective treatments, innovations in
surgery, improved health care, falling mortality rates and greater longevity.  Those telling this story recognised that
progress was not unalloyed, yet amongst doctors such was the step change in their effectiveness and efficiency that
problems, like the development of antibiotic resistance, were discounted or seen as something that would be solved by
further scientific and technological advances.  However, medical professionals soon realised that therapeutic and
technological advances often led to intractable problems; for example, the practice of managing the adverse effects of
one drug with another could lead to patients taking more medicines to manage side effects than for their primary
illness. Such practices were criticised in the 1960s, but for our narrative of fungal infections Ivan Illich’s book
Medical Nemesis, first published in 1975, is most relevant.  Illich made iatrogenesis – doctor induced disease –
central to his critique of modern medicine, claiming that around 10% of all clinical encounters were for such
conditions. He argued that the cures of modern medicine were often worse than the disease – if indeed there was a
disease in the first place, as Illich also attacked the medicalisation of everyday life, anticipating the burgeoning of
risk-defined conditions that emerged in the last quarter of the twentieth century.
Thrush, the most prevalent opportunistic mycosis of the twentieth century, exemplifies these trends. In the 1940s and
1950s, the emergence of resistant bacteria was only one side effect of the new drugs. More important then was the
development of so-called ‘superinfections’, also caused by antibiotics as they removed not just disease-causing
bacteria but many others, and altered the normal microbial flora of the body. These changes opened the body to
opportunistic infection by other bacteria, such as Staphylococcus aureus, and by fungi, especially Candida. This
fungus had previously only affected the ‘external’ mucus membranes in the mouth and genitalia, but emerged in the
1950s as a rare, but serious, internal and systemic infection, where fungi grew on major organs, such as the heart. It
was not just patients on antibiotics who were vulnerable. There were a growing number of patients whose immune
systems were weakened or immunocompromised. Initially, this situation developed as a side effect of steroids and
other similar treatments, but then such states were deliberately produced by doctors to aid the acceptance of
transplanted organs, or as a by-product of new cancer therapies. In 1987, John W. Rippon, a leading American
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The mycology of human infections in the 1980s is the mycology of the soil, rotting vegetables, shower curtains,
toilet bowls, leaf piles, wilted flowers and dung heaps. Organisms literally come out of the walls to infect
immunosuppressed patients. Technical medical and surgical expertise is such that we can pass around hearts,
lungs, and livers only to be thwarted by a Fusarium from a rotting plum.
Rippon was pointing to a larger truth about human fungal infections, namely, that their prevalence has been linked to
specific ecological conditions and interactions, not only within the body, but also within the wider social and physical
environment. At the time Rippon wrote, the United States, and soon the Western world, was gripped by a popular
health panic about fungal disease. Some fringe doctors promoted the view that Candida infection was responsible for
all manner of ‘modern’ ailments, including chronic fatigue syndrome (CFS) and inflammatory bowel disease (IBD),
in what they styled as ‘the yeast connection’.
In this book, we discuss the changing medical and public profile of fungal infections in the period 1850–2000. We
consider four sets of diseases: ringworm and athlete’s foot (dermatophytosis); thrush or candidiasis (infection with
Candida albicans); endemic, geographically specific infections in North America (coccidioidomycosis, blastomycosis
and histoplasmosis) and mycotoxins; and aspergillosis (infection with Aspergillus fumigatus). We discuss each disease
in relation to developing medical knowledge and practices, and to social changes associated with ‘modernity’. Thus,
mass schooling provided ideal conditions for the spread of ringworm of the scalp in children, and the rise of college
sports and improvement of personal hygiene led to the spread of athlete’s foot. Antibiotics seemed to open the body to
more serious Candida infections, as did new methods to treat cancers and the development of transplantation.
Regional fungal infections in North America came to the fore due to the economic development of certain regions,
where population movement brought in non-immune groups who were vulnerable to endemic mycoses. Fungal toxins
or mycotoxins were discovered as by-products of modern food storage and distribution technologies. Lastly, the rapid
development and deployment of new medical technologies, such as intensive care and immunosuppression in the last
quarter of the twentieth century, increased the incidence of aspergillosis and other systemic mycoses.
In understanding and managing infectious diseases, scientists and doctors have long argued for thinking about them in
terms of the metaphor of ‘seed and soil’, where the ‘seed’ is the infectious organism or pathogen: that is, virus,
bacteria, fungi, protozoa (single cell) or metazoan (multicellular); and the ‘soil’ is the human body and its environs.
Thus, for someone with the common cold, the notion of ‘seed and soil’ ensures that we go beyond focusing only on
infection by the virus (the seed) and consider the sufferer (the soil). This means looking at the conditions in which the
person was exposed to the virus, the quantity and quality of the virus reaching the body, the nature of the body’s
specific immune response and the overall health of the individual. We all know that we do not ‘catch a cold’ every
time we are exposed to the virus and that some people suffer longer and more serious illness than others do. Some
variations are individual, but epidemiological studies have always shown patterns of exposure, susceptibility, sickness
and recovery by age, gender, class, occupation, ethnicity and other socio-cultural variables. For example, in their
history of pulmonary tuberculosis, René and Jean Dubos systematically use the notion of ‘seed and soil’ to discuss the
disease at all levels, from biological factors influencing the susceptibility of cells and tissues, through to the socio-
economic and technological variables that have shaped global trends in morbidity and mortality.  In this book, we
frame our history of fungal infections in terms of ‘seed and soil’; hence, our ‘seeds’ are specific fungal pathogens and
we interpret ‘soils’ widely to include the human body, social relations and structures, and the medical, material and
technological environment.
Fungi
Fungi and how they cause diseases are not well known, so it will be useful here to give a brief introduction to the
nature of the ‘seeds’ of mycoses. Our account is part historical and part current.
Mycology is the branch of science that studies fungi and until the 1960s, it was a part of botany, at which time its
subject matter was moved to the animal kingdom. Since then, fungi have been placed in their own kingdom, with the
other four being plants, animals, protozoa and monera (bacteria).  Current estimates are that there are well over
100,000 species of fungi and many more are still to be classified, let alone discovered. Some fungi are large and
multicellular, like toad-stools. However, most species are microscopic, single cell organisms and are best known as
industrial agents (yeast fungi in the production of bread and beer) and as medical agents (Penicillia spp. remain the
source of the world’s mostly widely used antibiotic). The larger fungi develop as microscopic filaments called hyphae,
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Many writers divide fungi into ‘good’ and ‘bad’, judged by their impact on human existence; fungi themselves, of
course, are just filling niches that allow them to multiply and survive. In popular writing, the ‘good’ fungi are those
used in industrial processes or medicine, such as yeasts and penicillins mentioned above, plus those that can be eaten,
break down waste or work in plant roots to fix nitrogen. The ‘bad’ fungi are those that produce diseases in plants,
animals and humans. In terms of impact on humanity, fungi do most harm as causes of crop diseases and amongst
farm animals, but they are also a threat to homes, where their ability to breakdown organic matter is seen most
strikingly in the dry rot fungus which can destroy wooden structures very rapidly. Most fungi are saprophytic, that is,
they obtain their nutrients from breaking down organic matter, normally dead tissues, and absorbing the products to
‘feed’ their metabolism. They mostly live on or within the material on which they are feeding. A small number of
fungi, and of course the ones that concern medical mycologists, derive their nutrients from infecting living tissue,
either by destroying it, or through establishing a symbiotic relationship that affects human tissues and their
functioning.
Following long-established Linnaean principles, the classification of fungi was mainly by their reproductive and
sexual characteristics. Thus, the 1911 Encyclopaedia Britannica divided fungi into three groups: the Basidiomycota,
which produce club-like fruit bodies that spread spores (e.g. mushrooms); the Ascomycota, which produce fruit bodies
on special pods or sac structures (e.g. baker’s yeast, penicillin and most human fungal pathogens); and the
Phycomycetes that reproduce sexually by spores joining (e.g. black bread mould). These classifications held for most
of the twentieth century, though with many refinements and revisions with individual groups, genera and species.
Certain fungi proved very difficult to classify as they had different forms in different stages of their life cycle. In the
final decades of the century, the whole basis of ordering fungi changed as the new types of analysis of their DNA
(their genome or genotype) revealed different relationships from those of their form and function (phenotype). The
fluidity of understanding of the nature and classifications of fungi was evident with the microorganism known
currently as Pneumocystis jiroveci. Through the 1980s, this organism was regarded as a protozoan and named
Pneumocystis carinii, when it was the subject of extensive research as it was a major cause of pneumonia and death in
HIV/AIDS sufferers.  Indeed, Pneumocystis carinii pneumonia (PCP) was an early marker of the epidemic and
allegedly responsible for the deaths of celebrities such as Freddie Mercury. The redesignation of the organism as a
fungus was first made in 1988, based on work using the new techniques of DNA sequencing, though this remained
controversial until the late 1990s when the reclassification was finally accepted.
Fungal diseases
Geoffrey Ainsworth, who has written most extensively on the history of fungal diseases, argues that fungi are
amongst the oldest recognised causes of infection in humans.  Hippocrates seemingly wrote on ‘aphthae’ (sores in
the mouth) in 500 BC, which modern mycologists have identified as thrush. Two millennia later, ringworm infection
was present on the skin and in the hair of the subjects of Old Masters’ paintings. In the modern medical era, the first
systematic writings on fungi as a source of human disease were by the Hungarian born, Paris-based physician and
microscopist David Gruby in 1842–1844. At the time, fungi were understood to be the sources of a number of
diseases and attracted considerable scientific interest. In the 1830s, the Italian entomologist Agostino Bassi published
claims that the devastating muscardine disease of silkworms was due to a microscopic fungus Tritirachium shiotae,
which was eventually renamed in his honour as Beauveria bassiana.  Bassi was a major influence on Louis Pasteur,
both in his work on the silkworm diseases of pébrine and flacherie in the 1860s and on the idea that living
microorganisms might cause infectious diseases. The work of Bassi and Pasteur showed that fungal infections were,
and in fact still are, the cause of economic problems in agriculture and related industries.  Ainsworth goes on to
make the point that most ‘mycologists’ in Britain and the United States work as plant pathologists, with a disciplinary
allegiance to botany, and that medical mycologists were and remain quite a small minority, with a quite different
orientation.
In medicine in the 1830s, and in keeping with the then fashionable focus on pathological anatomy and lesions,
distinctive and specific fungal infections of the skin, such as favus and ringworm, were well recognised.
Classifications or nosologies of skin diseases were produced in the early nineteenth century, most influentially in
Thomas Bateman’s A Practical Synopsis of Cutaneous Diseases According to the Arrangement of Dr Willan (1813)
and an atlas The Delineations of Cutaneous Disease in 1817.  Many authors followed the French physician Jean
Louis Alibert in using extensive colour illustrations and some copied the wax models (les moulages) that he collected
at the Hôpital Saint-Louis in Paris.  The use of colour illustrations continued with photography, as in Charles-
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The contagious and infectious aspects of fungal disease meant that, from the 1860s, doctors and scientists regarded
them as ‘germ diseases’.  Early historians of germ theories of disease certainly traced the familiar lineage from van
Leeuwenhoek through Bassi to Pasteur, and the natural philosophers and medical men who used microscopy and
culturing to study fungi. David Gruby first linked specific fungi to favus, sycosis and ringworm infections of the
human scalp in the 1840s. For the latter, he first described the clinical condition of tinea tonsurans (scalp ringworm),
though the terms ‘herpes tonsurans’ and ‘teigne tondante’ also enjoyed currency.  In the 1850s, botanists and
dermatologists agreed on Trichophyton – literally hair-fungus due to its shape seen through microscopes – as the main
ringworm germ and, in line with the wider switch to naming diseases by their causes rather than their signs and
symptoms, in France tinea tonsurans became ‘trichophytie’. As we discuss in Chapter 1, these developments were
followed by leading dermatologists, such as William Tilbury Fox and Thomas M’Call Anderson, but most doctors and
dermatologists remained focused on morbid anatomy and nosologies based on signs and lesions.
Fungus theories of infectious disease were popular in the 1840s and the best known was the ‘cholera fungus’.  In a
paper read to the Microscopical Committee of the Bristol Literary and Philosophical Institution in 1849, ‘fungoid’
bodies were reported in the faeces of cholera sufferers.  The authors emphasised analogies between the growth and
decay of fungi, and the rise and fall of zymotic diseases in individuals and in populations over epidemic periods.
However, given that contemporaries thought that fungi were the ‘appointed executioners and nimble scavengers of
nature’, any such organisms were understood by contemporary doctors to be the consequences rather than the causes
of cholera. Medical views on the causal role of living organisms in disease waxed and waned from the 1840s to the
1880s, until bacterial germs were accepted as major pathogens.  At this time, bacteria were termed as the
‘Schizomycetes’, literally the splitting fungi, so named because they reproduced by the division of cells, and were
believed to be a type of fungi because of their microscopic form and physiological function as saprophytes.
One of the first British textbooks on the new science of germs was German Sims Woodhead and Arthur Hare’s
Pathological Mycology published in 1885.  However, this was the only time ‘mycology’ was used in this context;
the German term Bacteriologie soon took over. In the new manuals and textbooks on ‘bacteriology’ and
‘microbiology’, fungi as causes of infection were, at best, described briefly and typically in a final chapter or
appendix. For example, Muir’s and Ritchie’s influential Manual of Bacteriology, published in 1899, had a chapter
entitled ‘Non-Pathogenic Micro-organisms – Fungi’, and presented them as likely laboratory contaminants rather than
pathogens. The authors discussed Mucor spp., Oidium spp., Aspergillus niger, Penicillium glaucum, plus yeasts, and
ended with the comment, ‘Certain fungi closely related to the above are pathogenic agents.’ Readers were referred to
Anton De Bary’s Comparative Morphology and Biology of the Fungi, Mycetozoa and Bacteria, first published in
1886, for further details.
In the twentieth century, fungi were recognised as causing three types of disease in humans and animals. First, there
were infections where fungi develop parasitically in the tissues of the host, at (literally) three levels: superficial
mycoses, like athlete’s foot, where infection is limited to the outermost layers of the skin, nails and hair; subcutaneous
mycoses, like the tropical disease of Madura foot (mycetoma), where the growth extends to the underlying layers of
the skin and perhaps into bone; and systemic mycoses, like aspergillosis, where infection spreads through internal
organs and tissues.
Second, there were fungal poisons, either toxins in the fungi themselves, as with poisonous toadstools, or toxins
produced by the growth of fungi on foodstuffs, as with aflatoxins (produced by Aspergillus flavus). Third, there were
allergic reactions to fungal spores and moulds, which range from mild to acute, depending on the dose and
susceptibility of the host; thus, fungi are a common cause of asthma. There was a fourth type of disease that was
‘discovered’ in the 1980s and remains highly contested – ‘fungal overgrowth’. As we show in Chapter 3, this
condition has been widely dismissed by the medical profession as a fiction, yet it had wide currency with the public
and was linked to CFS and other ‘diseases of modernity’. In the cultural climate in North America and Europe, where
lifestyle was increasingly regarded as a cause, as well as a solution, to ill health, books such as William G. Crook’s
The Yeast Connection (1983), which attributed various chronic conditions to the overgrowth of C. albicans, became a
best seller and spawned many imitators. Crook also had the cure: dietary and lifestyle changes, plus a course of
antifungal antibiotics, which was surprising given his pedigree in ‘alternative medicine’.
The history of medical mycology
The multi-faceted career of medical mycology’s leading historian Geoffrey Ainsworth exemplifies the diverse and
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then pursued a dual career in plant pathology and medical mycology.  He first worked on the virus diseases of plants
at Britain’s two leading botanical institutions, the Rothamsted Experimental Station and the Experimental and
Research Station in Cheshunt. He spent the Second World War at the Imperial Mycological Institute at Kew,
developing abstracting services on all aspects of mycology. After the war, he moved to the pharmaceutical industry, as
head of the mycological department of the Wellcome Research Laboratories at Beckenham, Kent. There he led work
on the antibiotics produced by fungi, such as streptomycin and penicillin. He then moved, first, to the London School
of Hygiene and Tropical Medicine and later to the University of the South West (later the University of Exeter),
before returning to the now Commonwealth Mycological Institute, where he stayed until his retirement in 1968.
Ainsworth published widely on all aspects of fungi. His major works were Dictionary of the Fungi (1943), British
Smut Fungi (1950) with Kathleen Sampson, Medical Mycology (1952), and the multi-volume The Fungi: An
Advanced Treatise (1965–1973) with A. S. Sussman and F. K. Sparrow.
Towards the end of his career, Ainsworth developed an interest in the history of mycology and published three books
that have been immensely valuable in the research and writing of this book: Introduction to the History of Mycology
(1976), Introduction to the History of Plant Pathology (1981) and Introduction to the History of Medical and
Veterinary Mycology (1987).  In his preface to the latter volume, he sets out his approach and the scope of the topic.
Although possessing deep, if slender roots that can be traced back to ancient times, medical and veterinary
mycology is essentially a development of the twentieth century, especially the last fifty years during which time
several mycoses at first considered to be rarities have been shown to affect millions of men, women, and children
and their domesticated animals … . Here the attempt made to sketch in the historical background, by illustrating
the approaches to a series of basic problems, is limited to what might be described as the ‘natural history’ of
human and animal mycoses.
While we agree with Ainsworth on the point that the development of medical mycology was a phenomenon of the
twentieth century, our work differs in two ways. First, we do not take the specialism of medical mycology as given, or
historically constant, rather as a social institution that had to be created and sustained. Second, we do not set out a
lineage of ideas, but rather discuss changing knowledges in specific institutional and social settings, and also explore
practices and meanings.
The history of medical mycology in the United States in the twentieth century has been described in great detail in a
monograph by Ana Victoria Espinel-Ingroff published in 2006.  Her narrative is comprehensive and wonderfully
rich in characters and institutional detail. It focuses on training and mapping the professional networks that have
shaped medical mycology across the country. At the same time, the author tells the story of discoveries in the
understanding and management of the main fungal infections that affect Americans. It is history informed by
disciplinary politics, as Espinel-Ingroff’s reference point is what she sees as a crisis in medical mycology in the
United States. On the one hand, the importance of mycoses has grown with their increased prevalence and the arrival
of effective antifungal drugs. Yet, on the other hand, the field seems to be fragmenting, being drawn at one end to
molecular approaches and basic biology, and at the other to applied clinical research, leading to the neglect of the old,
middle ground of taxonomy, aetiology, physiology and pathogenesis.
Woven into Espinel-Ingroff’s history narrative is a narrative of developments in the field in the twentieth century, with
five periods defining her chapters. The discussion of the ‘Era of Discovery (1894–1919)’ explores how work on fungi
followed that in bacteriology in seeking the causal organisms of specific infections and the understanding of basic
fungal biology. The ‘Formative Years (1920–1949)’ are characterised by the establishment of training programmes,
laboratory services and epidemiological studies of common diseases, such as athlete’s foot and thrush, or the then
very rare systemic mycoses. The period 1950–1969, the ‘Advent of Antifungal and Immunosuppressive Therapies’,
was dominated by drug discoveries (nystatin, amphotericin B, griseofulvin) and the increased incidence of severe
opportunistic systemic fungal infections that were linked to antibiotics and immunosuppressive therapies. The ‘Years
of Expansion (1970–1979)’ are portrayed as the apogee of medical mycology, seen in the establishment of services to
deal with the increased incidence of infections, basic research to underpin clinical innovations and the recognition of
the specialty by the American Society for Microbiology (ASM). Finally, the ‘Era of Transition (1980–1996)’ saw
continued increase in the incidence of opportunistic infections in cancer and transplant patients, and amongst AIDS
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What few histories there are of fungal infections are largely embedded in accounts of the development of the specialty
of medical mycology, but there are a number of books and journal articles on specific infections. There is only one
monograph on a disease discussed in this book, Thomas Daniel and Gerald L. Baum’s Drama and Discovery: The
Story of Histoplasmosis.  Their narrative follows the emergence of the disease from social changes in its endemic
areas and the research networks in which new understandings of its epidemiology, aetiology, pathology and treatment
developed. It is typical of much work on the history of mycoses, as with Ainsworth and Espinel-Ingroff, in being
written by medical mycologists, but is quite different and richer as it explores the social as well as medical history of
histoplasmosis.  There are no book length histories of coccidioidomycosis and blastomycosis comparable to Drama
and Discovery, but there are very useful practitioner histories, for example, Jan Hirschmann’s account of the early
history of coccidioidomycosis in America.
Yet, as we have indicated, ‘biographies’ of mycoses written by medical historians are rare. Aspergillosis has no
thoroughgoing histories.  Ringworm has few historians in Britain and the United States, and even reflections by
practitioners are rare.  It has only excited attention in Israel, in relation to the controversy of the long-term effects on
children of X-ray treatment of the scalp and popular representations of the practice as the ‘Ringworm Holocaust’.  It
is also surprising that historians of medicine in the United States, who have thoroughly investigated popular
medications and health activism, have missed athlete’s foot, a condition that plagued not only the athletes but the
country’s youth, soldiers and miners.
Mycoses and medical history
In this book, we aim to do more than provide a narrative of a group of neglected infections. Our study also gives new
perspectives on the history of twentieth-century medicine on a number of fronts: specialisation; minor illnesses and
self-treatment; and ‘orphan diseases’. Firstly, we present an account of an area of medicine – medical mycology – that
for most of the twentieth century was small and marginal, and where practitioners struggled to establish an area of
specialist work. The development of specialisms and specialisation has long interested historians of medicine.
George Rosen’s study of ophthalmology was path breaking and work since then has linked the division of labour to
many factors within medicine and outside. George Weisz, in the most recent and comprehensive study on the topic,
finds that ‘divide and conquer’ best explains the overall process in medicine, as these terms ‘[express] a fundamental
intellectual strategy’, whereby medical professionals were, in a matter of a century, divided into ‘smaller and more
manageable groups based on common attributes’ and conquered by ‘organization based on a novel kind of
expertise’.
Most histories of specialisation and specialisms are of successful enterprises and can be teleological, charting the
seemingly inevitable journey to the present division of labour in medicine. Our narrative of medical mycology runs
against this grain, though it does not present medical mycology as a failed specialism, rather one, as Espinel-Ingroff’s
work makes clear, the position and status of which was always problematic. For most of the twentieth century, it was
small, institutionally fragmented and dispersed geographically. Its practitioners tried to ‘divide’ themselves off from
other specialisms but were relatively unsuccessful because their services were never in sufficient demand to form a
critical mass either numerically or politically. Thus, we challenge the accepted, though often implicit, view that
specialisation was an inevitable path in twentieth-century medicine, where it becomes ever more populated with full-
time ‘mono-specialists’; that is, clinicians and scientists who worked on a single disease or group of diseases, a
particular organ or organ system, specific technologies or a restricted patient group, say, by age or sex. Our research
on the doctors and researchers who treated and studied fungal infections shows a different, and perhaps equally
common, pattern of work: clinicians and scientists making a living as working in and combining a number of
specialisms.
We suggest that it is useful to think about twentieth-century medicine generally in terms of the doctors, and other
health workers for that matter, developing careers in a number of ‘specialist practices’. Historians of medicine often
overlook the fact that doctors and medical scientists had to ‘make a living’, and that in less wealthy times, when
health was a lower priority in private and state budgets, this was done by earning where they could and what they
could.  In this context, ‘medical mycology’ was an area of ‘specialist practice’ for certain botanists, dermatologists,
bacteriologists, hospital physicians and surgeons, infectious disease doctors, microbiologists, general practitioners or,
of course, combinations of these. Typically, ‘specialist practice’ was in cognate areas; hence, the first ‘medical
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nineteenth century few doctors were able to work full-time on skin diseases, so dermatologists were often general
practitioners, who functioned as part-time specialists, part-time in hospital outpatient clinics.
Secondly, and as noted already, fungal infections represent the over-whelming experience of illness, then and now,
like the common colds, sickness and diarrhoea, and sore throats that are self-limiting, self-treated or treated after one
short consultation with a general practitioner.  Research in the 1980s revealed that on average only one in 20
‘symptom episodes’ led to a medical consultation, a pattern that was termed the ‘iceberg of illness’.  If that was the
position in a country with a National Health Service, offering care that was ‘free at the point of delivery’, the
proportion would almost certainly be lower in pay-for-service medical and healthcare systems, then and now. There
are few studies, except for the era of ‘bedside medicine’, of the everyday experience of illness, and of decisions on
when and how to self-treat, and when and how to seek medical consultation and become a patient.  That said, our
focus is on the medical history of mycoses – a sufferer’s history would be quite different and, in fact, very difficult to
research. However, we do try to capture sufferers’ agency, for example, in our discussion of the proliferation of
proprietary remedies for athlete’s foot and thrush.
Thirdly, and at the other end of the scale of prevalence, systemic fungal infections have been classified as ‘orphan
diseases’; that is, those too rare to attract the attention of research agencies or the interest of many clinicians and
researchers.  The term originated in the United States and the Orphan Drug Act, 1983, promoted by the National
Organization for Rare Disorders and the Federal Drugs Agency (FDA). In the United States ‘orphan diseases’ are
those with a prevalence of less than 2,000 cases per year. By the end of the twentieth century, the rise in the incidence
of mycoses meant that this designation only applied to the geographically localised infections and the rarer types of
hospital acquired or nosocomial infections. Yet, for most of the twentieth century, opportunistic, invasive mycoses
were rare and medical mycologists and other interested parties bemoaned their neglect. In part, this was because such
infections were seen as ‘diseases of the diseased’ and affected patients who were seriously ill and close to death. In
fact, doctors spoke of these patients receiving ‘salvage therapies’, where ethical standards were different and there
was scope of experiment and the non-standard use of standard drugs. Interestingly, when invasive mycoses ceased to
be ‘rare’, they attracted the attention of many surgical and medical specialists, and researchers in pharmaceutical
companies, who sought to transfer their successes with mass market, external antifungals to invasive, systemic
disease. Indeed, the story of medical mycology in the second half of the twentieth century is dominated by the
development of new antifungal antibiotics, principally polyenes (e.g. nystatin and amphotericin B), azoles (e.g.
clotrimazole and ketoconazole), triazoles (e.g. fluconazole and itraconazole) and echinocandins (e.g. caspofungin),
targeted at the ‘seeds’ of infection.
The book
We discuss our four sets of infection in five chapters: two on ringworm (dermatophytosis), and one each on thrush,
the geographically specific mycoses and mycotoxins, and aspergillosis. We present histories of each disease group and
while our approach is essentially thematic, there is an overall movement through time. Thus, the first chapter on
ringworm begins in the mid-nineteenth century and ends around 1910, while the final chapter on aspergillosis is
mainly about changes in the last quarter of the twentieth century. Our narrative moves between Britain and the United
States following the changing locations where medical and social interest and activity was greatest. We are neither
comprehensive nor comparative in our discussion of medical mycology in these two national contexts. However, we
use the fact that work on fungal infections in the twentieth century, as demonstrated by the work of the International
Society for Human and Animal Mycology (ISHAM), was dominated by an Anglo-American axis, though this is not to
diminish in any way activities in other countries, which we discuss as appropriate.
Our first chapter frames ringworm as a disease of schools and schoolchildren. The disease had been reported
previously in orphanages and similar institutions, but its incidence and profile increased with the arrival of mass
schooling, which provided ideal conditions for its spread, both through increased opportunities for contagion
(seeding) and the exposure of poor children (weakened soil). We look at responses to the problem, one of which was
special schools for the isolation and treatment of sufferers, and which became sites for the use of the new X-ray
technologies, not to kill the seeds of infection, but to alter the soil by removing hair, the locus of infection. In the
second chapter, we move from head to toe, from Britain to the United States, and focus on athlete’s foot. Concern
over ringworm infection of the feet, along with infection of the crotch, armpit and similar areas of the body, began in
the 1920s, principally amongst sportsmen and women. Athlete’s foot was described as a perverse consequence of the
nation’s attempt to improve the health and fitness of its youth, especially with the burgeoning of college sports and

















presented in some instances as equivalent to a sexually transmitted disease, and by new methods of treatment
produced by the pharmaceutical industry, first in a rash of proprietary medicines and then antifungal antibiotics.
Thrush, the subject of our third chapter, was regarded at the start of the twentieth century as a disease of weak
children, but moved in the medical and public view to a genital infection, principally of women and was linked
mainly to alterations in the body due to pregnancy and lifestyle changes.  We then discuss how, in the second half of
the twentieth century, thrush was linked in different ways to the development of antibiotics. It was soon recognised as
a side effect of penicillin therapy, while the search for new and better bacterial antibiotics led to the discovery of
nystatin – the first modern antifungal antibiotic, which soon became a specific treatment for thrush. Systemic C.
albicans infection, known as invasive candidiasis, became, paradoxically, more prevalent in patients taking bacterial
antibiotics, but also in those with cancers, transplants and inflammatory conditions. This problem was met by a search
for new antifungal drugs, with successes improving the institutional position of medical mycology. We end the
chapter with a discussion of ‘The Yeast Connection’ phenomenon.
In Chapter 4, we discuss the regionally specific fungal infections in the United States that came to the fore as a
consequence of the economic development of certain regions in the South and Midwest, where population movement
brought in non-immune groups who were vulnerable to endemic mycoses. The forms of economic development were
also important, as new methods of production and types of industrial and domestic construction created new
environmental conditions, and in some cases literally transformed and transported fungi-laden soil dust. In the same
vein, we show how new technologies of food production, transportation and storage produced a new class of
hazardous compounds – mycotoxins. In our final chapter, we discuss aspergillosis, the most serious of the invasive
mycoses that have emerged from new medical technologies, such as intensive care and immunosuppression. An
important theme here is iatrogenesis, as attempts to control aspergillosis exemplified the now routine issue in modern
medicine of balancing the benefits and adverse effects of primary treatment, with secondary and tertiary interventions.
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